학술논문
509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01.
Document Type
Article
Author
Source
Subject
*NON-small-cell lung carcinoma
*DOCETAXEL
*METASTASIS
*
*
Language
ISSN
0923-7534